Matrices comprising a modified polysaccharide

US10968285B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10968285-B2
Application numberUS-201816000370-A
CountryUS
Kind codeB2
Filing dateJun 5, 2018
Priority dateAug 18, 2011
Publication dateApr 6, 2021
Grant dateApr 6, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention discloses a matrix comprising a modified polysaccharide consisting of repeating disaccharide units whereby in at least 11% of the disaccharide units one primary alcohol group is oxidized into a carboxylic acid group.

First claim

Opening claim text (preview).

The invention claimed is: 1. A plastic surgery implant consisting essentially of a matrix comprising: at least one modified polysaccharide consisting of repeating disaccharide units, wherein the primary alcohol group is oxidized to a carboxylic acid group in at least 11% of the disaccharide units, wherein the matrix further comprises at least one unmodified polysaccharide, wherein the weight ratio of the modified polysaccharide to unmodified polysaccharide in the matrix is greater than 10 wt % of a modified polysaccharide, and wherein the shear modulus G′ of the matrix is in the range of from 10 Pa to 10 7 Pa. 2. The plastic surgery implant of claim 1 , wherein the at least one modified polysaccharide is selected form the group consisting of a member of the carrageenan family, hyaluronic acid, heparin sulfate, dermatan sulfate, chondroitin sulfate, alginate, chitosan, pullulan, and agarose. 3. The plastic surgery implant of claim 1 , wherein the at least one modified polysaccharide is agarose. 4. The plastic surgery implant of claim 1 , wherein the at least one unmodified polysaccharide is selected from the group consisting of a member of the carrageenan family, hyaluronic acid, heparin sulfate, dermatan sulfate, chondroitin sulfate, alginate, chitosan, pullulan, and agarose. 5. The plastic surgery implant of claim 1 , wherein the at least one unmodified polysaccharide is agarose. 6. The plastic surgery implant of claim 1 , wherein the shear modulus G′ of the matrix is in the range of from 10 Pa to 100 kPa. 7. The plastic surgery implant of claim 1 , wherein one primary alcohol group is oxidized to a carboxylic acid group in at least 20-99% of the disaccharide units. 8. A method for reconstructive and cosmetic surgery, the method comprising implanting in plastic surgery a plastic surgery implant according to claim 1 . 9. A plastic surgery implant consisting essentially of a matrix comprising: at least one modified agarose consisting of repeating disaccharide units, wherein one primary alcohol group is oxidized to a carboxylic acid group in at least 11% of the disaccharide units, wherein the matrix further comprises at least one unmodified agarose, wherein the weight ratio of the modified polysaccharide to unmodified polysaccharide in the matrix is greater than 10 wt % of a modified polysaccharide, and wherein the shear modulus G′ of the matrix is in the range of from 10 Pa to 10 7 Pa.

Assignees

Inventors

Classifications

  • C08B37/00Primary

    Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof (cellulose D21; {microbiological processes C12P}) · CPC title

  • Cosmetics or similar toiletry preparations for specific uses not provided for in other groups of this subclass · CPC title

  • Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof · CPC title

  • Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof · CPC title

  • Agar; Agarose, i.e. D-galactose, 3,6-anhydro-D-galactose, methylated, sulfated, e.g. from the red algae Gelidium and Gracilaria; Agaropectin; Derivatives thereof, e.g. Sepharose, i.e. crosslinked agarose · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10968285B2 cover?
The present invention discloses a matrix comprising a modified polysaccharide consisting of repeating disaccharide units whereby in at least 11% of the disaccharide units one primary alcohol group is oxidized into a carboxylic acid group.
Who is the assignee on this patent?
Univ Freiburg Albert Ludwigs
What technology area does this patent fall under?
Primary CPC classification C08B37/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).